Ascendis Pharma AS (BSP:A1SN34) Accounts Payable & Accrued Expense : R$535 Mil (As of Mar. 2025)

View and export this data going back to 2020. Start your Free Trial

What is Ascendis Pharma AS Accounts Payable & Accrued Expense?

Ascendis Pharma AS's quarterly accounts payable & accrued expense increased from Sep. 2024 (R$469 Mil) to Dec. 2024 (R$624 Mil) but then declined from Dec. 2024 (R$624 Mil) to Mar. 2025 (R$535 Mil).

Ascendis Pharma AS's annual accounts payable & accrued expense declined from Dec. 2022 (R$592 Mil) to Dec. 2023 (R$518 Mil) but then increased from Dec. 2023 (R$518 Mil) to Dec. 2024 (R$624 Mil).

Ascendis Pharma AS Accounts Payable & Accrued Expense Historical Data

The historical data trend for Ascendis Pharma AS's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ascendis Pharma AS Accounts Payable & Accrued Expense Chart

Ascendis Pharma AS Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

138.93

380.92

591.90

517.58

623.62

Ascendis Pharma AS Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															529.71	583.35	468.86	623.62	534.99

Ascendis Pharma AS Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Ascendis Pharma AS Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ascendis Pharma AS (BSP:A1SN34) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

ASND:USA A71:Germany

Address

Tuborg Boulevard 12, Hellerup, DNK, DK-2900

Website

https://www.ascendispharma.com

Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.

Ascendis Pharma AS Headlines

No Headlines